Silvant Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,213
| Closed | -$87K | – | 378 |
|
|
2022
Q2 | $87K | Hold |
1,213
| – | – | 0.02% | 224 |
|
|
2022
Q1 | $119K | Hold |
1,213
| – | – | 0.02% | 214 |
|
|
2021
Q4 | $103K | Sell |
1,213
-78
| -6% | -$6.62K | 0.02% | 221 |
|
|
2021
Q3 | $103K | Hold |
1,291
| – | – | 0.02% | 220 |
|
|
2021
Q2 | $126K | Hold |
1,291
| – | – | 0.02% | 215 |
|
|
2021
Q1 | $151K | Hold |
1,291
| – | – | 0.03% | 202 |
|
|
2020
Q4 | $144K | Hold |
1,291
| – | – | 0.02% | 209 |
|
|
2020
Q3 | $153K | Hold |
1,291
| – | – | 0.03% | 193 |
|
|
2020
Q2 | $146K | Hold |
1,291
| – | – | 0.03% | 194 |
|
|
2020
Q1 | $86K | Hold |
1,291
| – | – | 0.02% | 205 |
|
|
2019
Q4 | $118K | Hold |
1,291
| – | – | 0.02% | 213 |
|
|
2019
Q3 | $111K | Buy |
1,291
+625
| +94% | +$53.7K | 0.02% | 216 |
|
|
2019
Q2 | $70K | Hold |
666
| – | – | 0.01% | 261 |
|
|
2019
Q1 | $83K | Hold |
666
| – | – | 0.01% | 241 |
|
|
2018
Q4 | $75K | Hold |
666
| – | – | 0.02% | 243 |
|
|
2018
Q3 | $143K | Buy |
666
+185
| +38% | +$39.7K | 0.02% | 212 |
|
|
2018
Q2 | $135K | Buy |
+481
| New | +$135K | 0.02% | 218 |
|